NYSE:VTR Ventas Q2 2026 Earnings Report $92.57 +0.05 (+0.05%) Closing price 07/2/2026 03:59 PM EasternExtended Trading$92.48 -0.09 (-0.10%) As of 07/2/2026 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Ventas EPS ResultsActual EPSN/AConsensus EPS $0.14Beat/MissN/AOne Year Ago EPSN/AVentas Revenue ResultsActual RevenueN/AExpected Revenue$1.68 billionBeat/MissN/AYoY Revenue GrowthN/AVentas Announcement DetailsQuarterQ2 2026Date7/29/2026TimeAfter Market ClosesConference Call DateThursday, July 30, 2026Conference Call Time10:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Ventas Earnings HeadlinesComparing RLJ Lodging Trust (NYSE:RLJ) and Ventas (NYSE:VTR)July 2 at 5:44 AM | americanbankingnews.comVentas Announces Second Quarter 2026 Earnings Release Date and Conference CallJune 29, 2026 | businesswire.comStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.July 5 at 1:00 AM | Porter & Company (Ad)Ventas Inc. stock underperforms Tuesday when compared to competitors despite daily gainsJune 24, 2026 | marketwatch.comVentas Names Andrew L. Wattula EVP Outpatient Medical & ResearchJune 22, 2026 | businesswire.comVentas Inc. stock underperforms Monday when compared to competitorsJune 16, 2026 | marketwatch.comSee More Ventas Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Ventas? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ventas and other key companies, straight to your email. Email Address About VentasVentas (NYSE:VTR) (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector. Ventas’ business model combines property ownership with active asset management and capital markets activity. The company leases space to a range of tenants that include senior living operators, healthcare systems, and research organizations, and it pursues a mix of ownership structures such as wholly owned properties and joint ventures. In addition to traditional real estate ownership, Ventas has historically provided structured financing and capital solutions to healthcare operators as part of its broader strategy to support operator stability and portfolio performance. Founded in the late 1990s, Ventas has grown into a large, publicly traded REIT focused primarily on North American healthcare real estate, with additional selective investments in other developed markets. The company emphasizes portfolio diversification across property types, geographies and tenant relationships, and it pursues acquisitions, dispositions and strategic partnerships to reposition assets and create long-term value. Ventas is overseen by an experienced management team and board of directors that guide its capital allocation, risk management and operational strategies in the healthcare real estate sector.View Ventas ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 06/29 - 07/03Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive WeaponVisa’s Open USD Push Puts Circle’s Stablecoin Moat Under PressureGeneral Mills Is a 5-Star Turnaround Play for Buy and Hold InvestorsCopper Stocks Are Getting a Bigger Spotlight as Gold’s Rally CracksNike Q4 Beat Masks Core Weakness as Analysts Cut Price TargetsIs the Memory Rally Still Alive After the Semiconductor Sell-Off? Upcoming Earnings PepsiCo (7/9/2026)Delta Air Lines (7/9/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026)Wells Fargo & Company (7/14/2026)Citigroup (7/14/2026)Fastenal (7/14/2026)Cintas (7/15/2026)ASML (7/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.